Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion type Assertion NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_head.
- NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion description "[KRAS mutations were identified in 23 (17.5%) of fully analysed patient samples (18 adenocarcinoma and five NSCLC-NOS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_provenance.
- NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion evidence source_evidence_literature NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_provenance.
- NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion SIO_000772 21949883 NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_provenance.
- NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion wasDerivedFrom befree-2016 NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_provenance.
- NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_assertion wasGeneratedBy ECO_0000203 NP926672.RA8jrQmGBK8hoHTUAkPq28rK5y48lvxQiPvdeZ2d1Bphg130_provenance.